Sorry, you need to enable JavaScript to visit this website.

Scaling Up to Manufacture and Supply a COVID-19 Vaccine, If Approved

Pfizer has a long and proud history of manufacturing vaccines. In 2019 alone, our vaccines helped to protect more than 69 million people from potentially life-threatening diseases.

We are taking a number of steps to scale up manufacturing operations at risk to accelerate our ability to supply a potential novel vaccine for COVID-19, subject to the vaccine demonstrating effectiveness and gaining approval. We have been planning and developing a strategy to ensure we are able to manufacture large quantities of a vaccine as quickly and safely as possible for patients.

Learn more about our manufacturing and global supply capabilities:

Vaccines_Infographic_Version1_August2020

Vaccines_Infographic_Version1_August2020 Infographic 2

We have been planning and developing a strategy to ensure we are able to manufacture large quantities of a vaccine as quickly and safely as possible for patients.

MORE ON COVID-19
How to stay safe and prevent the spread.